These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

979 related items for PubMed ID: 12126553

  • 1. [Changes of proinflammatory cytokines and their receptors in serum from patients with pulmonary tuberculosis].
    Tang S, Xiao H, Fan Y, Wu F, Zhang Z, Li H, Yang Y.
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jun; 25(6):325-9. PubMed ID: 12126553
    [Abstract] [Full Text] [Related]

  • 2. [Soluble cytokinin receptors in renal vasculitis and lupus nephritis].
    Tesar V, Jirsa M, Masek Z, Bartůnková J, Stejskalová A, Dostál C, Zabka J, Chábová V, Rysavá R.
    Cas Lek Cesk; 1998 May 04; 137(9):271-5. PubMed ID: 9650355
    [Abstract] [Full Text] [Related]

  • 3. Soluble cytokine receptors in renal vasculitis and lupus nephritis.
    Tesar V, Jirsa M, Zima T, Kalousová M, Bartunková J, Stejskalová A, Dostál C, Zabka J.
    Med Sci Monit; 2002 Jan 04; 8(1):BR24-9. PubMed ID: 11782670
    [Abstract] [Full Text] [Related]

  • 4. [Investigation of soluble tumor necrosis factor receptor in patients with active tuberculosis].
    Onohara Y, Tomoda K, Nakaya M, Yoshikawa M, Tsukaguchi K, Tokuyama T, Hu A, Hukuoka K, Yamamoto C, Yoneda T, Narita N.
    Kekkaku; 1996 Jul 04; 71(7):435-8. PubMed ID: 8776958
    [Abstract] [Full Text] [Related]

  • 5. Soluble TNF and IL-2 receptors in patients with breast cancer.
    Tesarová P, Kvasnicka J, Umlaufová A, Homolková H, Jirsa M, Tesar V.
    Med Sci Monit; 2000 Jul 04; 6(4):661-7. PubMed ID: 11208388
    [Abstract] [Full Text] [Related]

  • 6. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
    Robak T, Gladalska A, Stepień H.
    Eur Cytokine Netw; 1998 Jun 04; 9(2):145-54. PubMed ID: 9681390
    [Abstract] [Full Text] [Related]

  • 7. Increased synovial fluid levels of interleukin-12, sCD25 and sTNF-RII/sTNF-RI ratio delineate a cytokine pattern characteristic of immune arthropathies.
    Ribbens C, André B, Kaye O, Kaiser MJ, Bonnet V, de Groote D, Franchimont N, Malaise MG.
    Eur Cytokine Netw; 2000 Dec 04; 11(4):669-76. PubMed ID: 11125312
    [Abstract] [Full Text] [Related]

  • 8. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
    Seitz M, Zwicker M, Villiger PM.
    J Rheumatol; 2003 Jan 04; 30(1):28-35. PubMed ID: 12508386
    [Abstract] [Full Text] [Related]

  • 9. [Tumor necrosis factor alpha and its soluble receptors in serum of patients with coronary artery disease].
    Mizia-Stec K, Mandecki T, Zahorska-Markiewicz B, Janowska J, Szulc A, Jastrzebska-Maj E, Szymański L.
    Pol Merkur Lekarski; 2001 Jul 04; 11(61):19-25. PubMed ID: 11579824
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1a.
    Perini P, Tiberio M, Sivieri S, Facchinetti A, Biasi G, Gallo P.
    Eur Cytokine Netw; 2000 Mar 04; 11(1):81-6. PubMed ID: 10705303
    [Abstract] [Full Text] [Related]

  • 11. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
    Rutkowski P, Kamińska J, Kowalska M, Ruka W, Steffen J.
    J Surg Oncol; 2003 Nov 04; 84(3):151-9. PubMed ID: 14598359
    [Abstract] [Full Text] [Related]

  • 12. Cytokines and heart rate variability in patients with chronic heart failure.
    Straburzyńska-Migaj E, Ochotny R, Wachowiak-Baszyńska A, Straburzyńska-Lupa A, Leśniewska K, Wiktorowicz K, Cieśliński A.
    Kardiol Pol; 2005 Nov 04; 63(5):478-85; discussion 486-7. PubMed ID: 16362851
    [Abstract] [Full Text] [Related]

  • 13. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients.
    Ocvirk J, Stabuc B, Rudolf Z, Galvani V, Curin-Serbec V.
    Melanoma Res; 2000 Jun 04; 10(3):253-8. PubMed ID: 10890379
    [Abstract] [Full Text] [Related]

  • 14. Effects of an intravenous catheter on the local production of cytokines and soluble cytokine receptors in healthy men.
    Haack M, Reichenberg A, Kraus T, Schuld A, Yirmiya R, Pollmächer T.
    Cytokine; 2000 Jun 04; 12(6):694-8. PubMed ID: 10843747
    [Abstract] [Full Text] [Related]

  • 15. [Proinflammatory cytokines in inactive lupus erythematosus patients].
    Lesiak A, Sysa-Jedrzejowska A, Narbutt J, Lukamowicz J, Robak E, Wozniacka A.
    Przegl Lek; 2005 Jun 04; 62(9):838-42. PubMed ID: 16541713
    [Abstract] [Full Text] [Related]

  • 16. Effects of estrogen therapy of postmenopausal women on cytokines measured in peripheral blood.
    Rogers A, Eastell R.
    J Bone Miner Res; 1998 Oct 04; 13(10):1577-86. PubMed ID: 9783546
    [Abstract] [Full Text] [Related]

  • 17. [Soluble TNF and IL-2 receptors in patients with breast carcinoma].
    Tesarová P, Kvasnicka J, Umlaufová A, Homolková J, Jirsa M, Tesar V.
    Cas Lek Cesk; 1998 May 25; 137(11):341-5. PubMed ID: 9727208
    [Abstract] [Full Text] [Related]

  • 18. Drug-induced urticaria--activity of selected cytokines and acute phase proteins in plasma.
    Czelej D, Chodorowska G, Lechowska-Mazur I.
    Ann Univ Mariae Curie Sklodowska Med; 2003 May 25; 58(1):38-42. PubMed ID: 15314956
    [Abstract] [Full Text] [Related]

  • 19. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders.
    Kaneyama K, Segami N, Sun W, Sato J, Fujimura K.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar 25; 99(3):276-84. PubMed ID: 15716832
    [Abstract] [Full Text] [Related]

  • 20. The combination of intermediate doses of thalidomide and dexamethasone reduces bone marrow micro-vessel density but not serum levels of angiogenic cytokines in patients with refractory/relapsed multiple myeloma.
    Hatjiharissi E, Terpos E, Papaioannou M, Hatjileontis C, Kaloutsi V, Galaktidou G, Gerotziafas G, Christakis J, Zervas K.
    Hematol Oncol; 2004 Dec 25; 22(4):159-68. PubMed ID: 15991268
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.